PCSK9 and cardiovascular disorder: These conditions may promote enhanced activation of sterol regulatory element-binding protein 2 (SREBP2) and hepatocyte nuclear factor-1 alpha (HNF1α) dependent transcription of PCSK9, thereby linking tobacco exposure to impaired lipid metabolism and increased cardiovascular disease risk [33].